We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.72B
AUM Growth
+$313M
Cap. Flow
+$128M
Cap. Flow %
4.71%
Top 10 Hldgs %
27.21%
Holding
156
New
12
Increased
32
Reduced
20
Closed
11

Top Buys

Rank Stock Value
1
SEND
SendGrid, Inc.
SEND
+$62.1M
2
ALTR
Altair Engineering Inc
ALTR
+$38.1M
3
ZGNX
Zogenix, Inc.
ZGNX
+$35.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.5M
5
ARGX icon
argenx
ARGX
+$20.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$42M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$29.8M
3
W icon
Wayfair
W
+$28.7M
4
IDTI
Integrated Device Technology I
IDTI
+$26.3M
5
ELLI
Ellie Mae Inc
ELLI
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.7%
2 Technology 19.3%
3 Consumer Discretionary 10.25%
4 Industrials 6.97%
5 Communication Services 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRCX icon
26
Lam Research
LRCX
$372B
$34.4M 1.26%
2,270,000
– –
STLD icon
27
Steel Dynamics
STLD
$36.2B
$34.1M 1.25%
754,000
– –
CCI icon
28
Crown Castle
CCI
$33.4B
$34M 1.25%
305,000
– –
COLL icon
29
Collegium Pharmaceutical
COLL
$1.17B
$32.5M 1.2%
2,207,610
– –
ASML icon
30
ASML
ASML
$634B
$32.3M 1.19%
172,000
– –
MGA icon
31
Magna International
MGA
$19B
$32.2M 1.18%
613,700
-800
-0.1% -$44.9K
STKL
32
DELISTED
SunOpta
STKL
$31.6M 1.16%
4,300,540
– –
WBC
33
DELISTED
WABCO HOLDINGS INC.
WBC
$30.1M 1.11%
255,600
– –
INST
34
DELISTED
Instructure, Inc.
INST
$28.5M 1.05%
805,796
-136,204
-14% -$5.59M
LEA icon
35
Lear
LEA
$7.33B
$26.7M 0.98%
184,000
– –
DNTH icon
36
Dianthus Therapeutics
DNTH
$6.16B
$26.3M 0.96%
139,881
– –
ANAB icon
37
AnaptysBio
ANAB
$1.63B
$26.2M 0.96%
262,275
+190,275
+264% +$15.8M
LII icon
38
Lennox International
LII
$14.5B
$25.8M 0.95%
118,000
– –
ROP icon
39
Roper Technologies
ROP
$38.5B
$25.8M 0.95%
87,000
– –
ARGX icon
40
argenx
ARGX
$54.6B
$25.4M 0.93%
335,000
+235,000
+235% +$20.8M
ECYT
41
DELISTED
Endocyte, Inc. Common Stock
ECYT
$23.3M 0.86%
1,314,000
+964,000
+275% +$16.6M
APTV icon
42
Aptiv
APTV
$12.3B
$22.6M 0.83%
269,600
+10,400
+4% +$950K
BPMC
43
DELISTED
Blueprint Medicines
BPMC
$22M 0.81%
282,000
+132,000
+88% +$9.17M
PEGI
44
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$21.2M 0.78%
1,065,500
+2,500
+0.2% +$48.2K
IPHI
45
DELISTED
INPHI CORPORATION
IPHI
$21.1M 0.77%
555,000
– –
QURE icon
46
uniQure
QURE
$2.93B
$20.7M 0.76%
569,700
-184,350
-24% -$6.86M
VCYT icon
47
Veracyte
VCYT
$4.77B
$20.4M 0.75%
2,133,500
– –
KALV
48
DELISTED
KalVista Pharmaceuticals
KALV
$19.9M 0.73%
900,000
– –
MYOK
49
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$19.7M 0.72%
302,000
– –
NBIX icon
50
Neurocrine Biosciences
NBIX
$18.7B
$19.2M 0.7%
156,000
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Eventide Asset Management held 156 positions worth $2.72B, up 13% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $128M of net new capital in Q3 2018, opening 12 new positions and adding to 32 existing holdings. Its largest new stake was SendGrid, Inc.: 1,968,653 shares worth $72.4M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $42M trimmed.

  • Eventide Asset Management's largest Q3 2018 buy was SendGrid, Inc.: 1,968,653 shares worth $72.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q3 2018, an estimated $35.9M increase.
  • Eventide Asset Management's biggest Q3 2018 reduction was AbbVie, cutting an estimated $42M.
  • Eventide Asset Management fully exited Integrated Device Technology I in Q3 2018, selling an estimated $26.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $2.72B portfolio in Q3 2018.
  • Eventide Asset Management opened 12 new positions and closed 11 in Q3 2018.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.72B.

Based on Eventide Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.